Second quarter revenues were $6,831,578 compared to $6,985,312 recorded in the same period last year; resulting in net income of $206,672 or $.01 per diluted share versus *net income of $1,230,220 or $.07 per diluted share in the prior year.

Six month revenues were $14,048,901 compared to $13,662,879 reported during the first six months of 2008.

Net income totaled $605,885 or $.03 per diluted share versus *net income of $1,420,664 or $.08 per diluted share in the comparable period last year.

*During the second quarter of 2008, the Company realized a gain of $1,495,634 from the acquisition of intellectual property in a non-monetary exchange from a contract settlement.

Andrew Makrides, president of Bovie, stated, "Our focus remains on new product development and commercialization of these products in order to deliver future earnings and revenue growth. In addition, we continue to hold discussions with larger companies as potential partners and agreements remain a viable possibility."

Recently submitted new products pending Food and Drug Administration clearance:

J-plasma system (ICON GS Electrosurgical generator and handpiece).

Laparoscopic SEER device for solid organ resection.

BOSS soft tissue coagulation device.

Seal-N-Cut vessel sealing line of hybrid monopolar and bipolar forceps.

ICON VS electrosurgical generator designed to work with the Seal-N-Cut vessel sealing instruments.

This document may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings. www.boviemedical.com

  BOVIE MEDICAL CORPORATION                                                                                                                 CONDENSED STATEMENTS OF OPERATIONS                                                                                                        FOR THE THREE AND SIX-MONTH PERIODS                                                                                                                                                                                                                                                                                                                                                                                                                                                         Three Months Ended June 30,           Six Months Ended June 30,                                                                                                                                                                                                                                                                                                                                                                  2009               2008               2009               2008                                                                                                                                                      Revenues                                                      $  6,831,578       $  6,985,312       $  14,048,901      $  13,662,879      Cost of Sales                                                 $  3,850,436       $  4,084,859       $  7,747,945       $  8,176,501                                                                                                                                                 Gross Profit                                                  $  2,981,142       $  2,900,453       $  6,300,956       $  5,486,378                                                                                                                                                 Costs & Expenses                                              $  2,705,328       $  2,655,011       $  5,486,538       $  4,951,983       Gain (Loss) from operations                                   $  275,814         $  245,442         $  814,418         $  534,395                                                                                                                                                   Interest, net                                                    (11,220     )      8,946              56,389             30,673                                                                                                                                                    Gain on cancellation of agreement                                --                 1,495,634          --                 1,495,634                                                                                                                                                 Net Income (loss) before minority interest and income taxes   $  264,594         $  1,750,022       $  870,807         $  2,060,702                                                                                                                                                 Benefit (provision) for income taxes                          $  (57,922     )   $  (519,802    )   $  (264,922    )   $  (640,038    )                                                                                                                                             Net Income (loss)                                             $  206,672         $  1,230,220       $  605,885         $  1,420,664       EPS (loss) Basic                                                 .01                .08                .04                .09             EPS (loss) Diluted                                               .01                .07                .03                .08                                                                                                                                                       Weighted average shares                                          16,879,182         16,002,841         16,866,160         15,962,852      Outstanding                                                                                                                                                                                                                                                                         Weighted average shares                                          17,818,101         17,803,069         17,762,124         17,708,156      adjusted for dilutive securities                                                                                                           -------------------------------------------------------------------------------  

A service of YellowBrix, Inc.